Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Tuukka A, Helin"'
Publikováno v:
Thrombosis Journal, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Background Coronavirus-19 disease (COVID-19) frequently causes coagulation disturbances. Data remains limited on the effects of microRNAs (miRNAs) on coagulation during COVID-19 infection. We aimed to analyze the comprehensive miRNA profile
Externí odkaz:
https://doaj.org/article/0f4b8755a6f14d3894d0319500078ee6
Publikováno v:
BMJ Open, Vol 13, Iss 11 (2023)
Objectives We studied association of laboratory testing beyond the international normalised ratio (INR) with bleeding and stroke/transient ischaemic attack (TIA) outcomes in patients with atrial fibrillation treated with warfarin.Design This was a re
Externí odkaz:
https://doaj.org/article/611e387f8c0647b3be3c52fd6bc2c8d7
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 5, Iss 3, Pp 439-446 (2021)
Abstract Background The thrombin generation (TG) assay is a feasible but labor‐intensive method for detecting global coagulation. It enables comprehensive assessment of anticoagulation, while drug‐specific assays assess only exposure. Traditional
Externí odkaz:
https://doaj.org/article/ef75b56cf1274601a77cff309d1e0a53
Publikováno v:
Diagnostics, Vol 12, Iss 10, p 2520 (2022)
Direct oral anticoagulants (DOAC) interfere in laboratory coagulation testing. The aim here was to study how commercial DOAC removal methods, DOAC Filter® and DOAC-Stop™, perform to eliminate DOAC concentrations and false positive results in lupus
Externí odkaz:
https://doaj.org/article/90a8dd4b7c8d4915b4b765a6dc62043a
Autor:
Tuukka A, Helin, Marleen, Zuurveld, Mikko, Manninen, Joost C M, Meijers, Riitta, Lassila, Herm Jan M, Brinkman
Publikováno v:
Transfusion. 58(12):3014-3026
BACKGROUND: Uncontrollable bleeding is the leading cause of death in traumatically injured patients. The extent to which direct factor Xa inhibitors interfere with the applied resuscitation measures is presently unknown. STUDY DESIGN AND METHODS: In
Autor:
Tuukka Antero Helin, Tuula Metso, Jukka Holvitie, Kirsi Valtonen, Riitta Lassila, Tiina Mäki, Lotta Joutsi-Korhonen
Publikováno v:
University of Helsinki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::56548565829b93bc7a567a9fbc8b4f94
http://hdl.handle.net/10138/225953
http://hdl.handle.net/10138/225953
Publikováno v:
University of Helsinki
English summary.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a5eccdb7704807861a4aca9f51b12ef4
https://researchportal.helsinki.fi/en/publications/e1816e81-9bfd-410b-a276-e7ab31e6ea7b
https://researchportal.helsinki.fi/en/publications/e1816e81-9bfd-410b-a276-e7ab31e6ea7b
Publikováno v:
University of Helsinki
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b84f6a06bee97fa983bc8cfe65d53d24
https://researchportal.helsinki.fi/en/publications/2412553f-a0cd-4f64-ab79-01c65881f49e
https://researchportal.helsinki.fi/en/publications/2412553f-a0cd-4f64-ab79-01c65881f49e
Autor:
Tuukka Antero Helin
Publikováno v:
University of Helsinki
Direct oral anticoagulants (DOACs), the thrombin inhibitor dabigatran and the anti-Xa inhibitors rivaroxaban and apixaban are are simple to use as standard dosing is recommended and no routine monitoring of coagulation is advocated. However, in certa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0ff4e0b2144964a2797607af01b9d124
https://researchportal.helsinki.fi/en/publications/4881667f-e806-401c-af1c-095a3153d98e
https://researchportal.helsinki.fi/en/publications/4881667f-e806-401c-af1c-095a3153d98e